What's breaking now, across thousands of outlets.
“Too often, regulatory tools authorized to speed patient access to breakthrough treatments are being used in ways that even prevent approval,” writes Kat Bryant Knudson.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
Why NCISM says Ayurveda, Unani, Siddha, and Sowa-Rigpa doctors cannot be called “quacks”
Today we welcome Gene Mack, President and CEO of Gain Therapeutics. Their lead candidate is advancing toward Phase 2 as a potential first-in-class disease-modifying therapy for Parkinson’s disease The…
As the death toll rises to almost 1,500, and with a vaccine against the Bundibugyo strain potentially still months away, health workers face a battle to slow the outbreak The latest numbers of…
A months-long DW investigation into childbirth in Serbia revealed a striking pattern in women's negative experiences, the widespread use of practices not universally recommended by the WHO and a…
Kris DeVault is desperate. His son, Brody, was born in March 2023. It wasn’t long before he started to show signs of developmental delay, says DeVault.
New tests for Alzheimer's are helping people who are at risk of dementia get clarity on their condition, Live Science reports from the Alzheimer's Association International Conference in London.
